Abiomed Ord Shs (ABMD)
$310.82 4.16 (1.32%)
16:16 EDT ABMD Stock Quote Delayed 30 Minutes
Previous Close $310.82
Market Cap 13.82B
PE Ratio 126.87
Volume (Avg. Vol.) 445,400
Day's Range 307.44 - 316.88
52-Week Range 119.01 - 319.19
Dividend & Yield N/A (N/A)
ABMD Stock Predictions, Articles, and Abiomed Ord Shs News
- From InvestorPlace
- From the Web
From a list of the 20 best-performing S&P 500 stocks of the past decade, I’ve selected seven that I feel can deliver a repeat performance.
Thursday's big stock charts feature names with intriguing bull cases. All are looking for support in a market that hasn't yet found a bottom.
2019 has been one of the best years for stocks in recent memory. Heading into 2020, here are 10 stocks to buy that are struggling to finish well.
ABMD, ULTA and BIDU have all fallen out of favor. But each of these growth stocks to buy still has what it takes to make a big-time comeback.
These 7 growth stocks remain positioned for significant future increases, and could bring huge returns to new investors for years to come.
While the markets have roared higher in 2019, these stocks have been crashing. But some of them could rebound soon.
If you follow the smart money, you end up following these stocks to buy. Here's what you should know about each.
Not all stocks lost out in 2018. These are the strong-buy stocks that emerged victorious from a year of extremely volatile trading.
The markets may be volatile but the trends for these tech stocks are strong.
As we move toward the start of a new year, the best stocks are not only showing their strength now, but can carry it forward. These 10 make the list!
October has been volatile, but some stocks offer safety from the storm. Whether you’re just starting out or an investing veteran, these are core stocks to buy.
These are the 10 best stocks to buy now. Regardless of market conditions, they should continue to climb for years to come.
Medical device stocks could be the best play in all of healthcare. Here are five of the best choices for any portfolio.
Navellier RatingsPowered by Portfolio Grader